Sg Americas Securities, LLC Corcept Therapeutics Inc Transaction History

Sg Americas Securities, LLC

  • $30.5 Billion
  • Q1 2025

A detailed history of Sg Americas Securities, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 43,109 shares of CORT stock, worth $3.19 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
43,109
Previous 11,187 285.35%
Holding current value
$3.19 Million
Previous $564,000 773.05%
% of portfolio
0.02%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025
BUY
$49.85 - $114.22 $1.59 Million - $3.65 Million
31,922 Added 285.35%
43,109 $4.92 Million
Q4 2024

Jan 17, 2025
SELL
$44.66 - $60.85 $825,138 - $1.12 Million
-18,476 Reduced 62.29%
11,187 $564,000
Q3 2024

Oct 03, 2024
BUY
$29.51 - $46.26 $633,845 - $993,618
21,479 Added 262.45%
29,663 $1.37 Million
Q2 2024

Jul 12, 2024
BUY
$22.21 - $34.48 $30,050 - $46,651
1,353 Added 19.81%
8,184 $266,000
Q1 2024

May 06, 2024
SELL
$21.1 - $27.46 $4.37 Million - $5.68 Million
-206,979 Reduced 96.81%
6,831 $172,000
Q4 2023

Jan 12, 2024
BUY
$24.82 - $32.88 $798,831 - $1.06 Million
32,185 Added 17.72%
213,810 $6.95 Million
Q3 2023

Oct 13, 2023
BUY
$21.97 - $33.8 $1.83 Million - $2.81 Million
83,149 Added 84.44%
181,625 $4.95 Million
Q2 2023

Jul 10, 2023
SELL
$21.44 - $25.15 $1.84 Million - $2.15 Million
-85,620 Reduced 46.51%
98,476 $2.19 Million
Q1 2023

Apr 28, 2023
BUY
$19.2 - $24.47 $3.27 Million - $4.17 Million
170,491 Added 1253.15%
184,096 $3.99 Million
Q4 2022

Feb 02, 2023
BUY
$19.95 - $29.96 $259 - $389
13 Added 0.1%
13,605 $276,000
Q3 2022

Oct 31, 2022
SELL
$24.7 - $29.12 $566,148 - $667,459
-22,921 Reduced 62.77%
13,592 $348,000
Q2 2022

Jul 29, 2022
SELL
$17.33 - $25.3 $11.8 Million - $17.2 Million
-679,670 Reduced 94.9%
36,513 $868,000
Q1 2022

Apr 29, 2022
BUY
$16.53 - $25.21 $7.08 Million - $10.8 Million
428,323 Added 148.8%
716,183 $16.1 Million
Q4 2021

Feb 07, 2022
BUY
$17.1 - $23.34 $3.4 Million - $4.65 Million
199,095 Added 224.29%
287,860 $5.7 Million
Q3 2021

Nov 01, 2021
BUY
$19.68 - $22.53 $1.65 Million - $1.89 Million
83,762 Added 1674.24%
88,765 $1.75 Million
Q2 2021

Aug 12, 2021
SELL
$19.97 - $24.43 $212,121 - $259,495
-10,622 Reduced 67.98%
5,003 $110,000
Q1 2021

May 13, 2021
SELL
$23.49 - $30.56 $2.42 Million - $3.15 Million
-103,047 Reduced 86.83%
15,625 $372,000
Q4 2020

Feb 04, 2021
SELL
$16.78 - $27.3 $2.39 Million - $3.89 Million
-142,365 Reduced 54.54%
118,672 $3.1 Million
Q3 2020

Nov 09, 2020
BUY
$12.46 - $19.98 $98,172 - $157,422
7,879 Added 3.11%
261,037 $4.54 Million
Q2 2020

Jul 20, 2020
BUY
$11.0 - $18.26 $784,311 - $1.3 Million
71,301 Added 39.21%
253,158 $4.26 Million
Q1 2020

Apr 30, 2020
BUY
$10.11 - $14.04 $1.31 Million - $1.83 Million
130,018 Added 250.81%
181,857 $2.16 Million
Q4 2019

Jan 28, 2020
BUY
$12.06 - $16.96 $460,209 - $647,193
38,160 Added 278.97%
51,839 $627,000
Q3 2019

Nov 04, 2019
BUY
$10.41 - $14.66 $43,534 - $61,308
4,182 Added 44.03%
13,679 $193,000
Q2 2019

Jul 29, 2019
SELL
$9.78 - $12.76 $21,692 - $28,301
-2,218 Reduced 18.93%
9,497 $106,000
Q1 2019

Apr 29, 2019
SELL
$10.03 - $15.71 $1.65 Million - $2.58 Million
-164,064 Reduced 93.34%
11,715 $138,000
Q4 2018

Feb 01, 2019
BUY
$11.29 - $17.19 $1.9 Million - $2.89 Million
168,188 Added 2215.62%
175,779 $2.35 Million
Q3 2018

Nov 06, 2018
SELL
$12.27 - $15.65 $176,074 - $224,577
-14,350 Reduced 65.4%
7,591 $106,000
Q2 2018

Aug 07, 2018
BUY
$15.3 - $19.69 $335,697 - $432,018
21,941 New
21,941 $345,000

Others Institutions Holding CORT

# of Institutions
441
Shares Held
84.7M
Call Options Held
1.04M
Put Options Held
1.33M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $7.92B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email